Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study Article

sustainable development goals

publication date

  • March 1, 2018

webpage

published in

start page

  • 403

end page

  • 410

volume

  • 32

issue

  • 3